Interestingly, STAT1 increases the expression of interleukin-18 binding protein (IL-18BP) and indoleamine 2,3-dioxygenase (IDO), an immunosuppressive enzyme that suppresses anti-tumor immunity. Here, IDO1 is linked to neoplasm.